20 completed, 10 recruiting, 4 terminated, 3 not yet recruiting. 13 Phase 2, 10 Phase 3, 7 Not applicable, 2 Phase 1, 2 Phase 4.
Follow Aspergillosis, Allergic Bronchopulmonary: new trials by email Literature Review of Aspergillosis, Allergic Bronchopulmonary trials Research Report on Aspergillosis, Allergic Bronchopulmonary
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Real-World Effectiveness of Depemokimab in Allergic Bronchopulmonary Aspergillosis With Severe Eosinophilic Asthma Depemokimab - Allergic Bronchopulmonary Aspergillosis, ABPA | Not applicable | Not yet recruiting | Qianfoshan Hospital | 10 | 2026-11-01 | 2026-09-24 |
| Real-World Effectiveness of Tezepelumab in Allergic Bronchopulmonary Aspergillosis Tezepelumab - Allergic Bronchopulmonary Aspergillosis, Severe Asthma | Not applicable | Not yet recruiting | Qianfoshan Hospital | 10 | 2026-09-01 | 2026-08-11 |
| A Study of the Efficacy and Safety of Bronchoscopic Airway Clearance and Amphotericin B Spraying in Patients With ABPA The patients were treated with bronchoscopic airway clearance and amphotericin B spraying - ABPA, Allergic Bronchopulmonary Aspergillosis | Recruiting | Qianfoshan Hospital | 44 | 2026-01-10 | 2026-01-23 | |
| Real-World Effectiveness of Benralizumab in Allergic Bronchopulmonary Aspergillosis Fasenra - Allergic Bronchopulmonary Aspergillosis, Severe Asthma | Recruiting | Qianfoshan Hospital | 20 | 2025-09-01 | 2026-04-21 | |
| Immune Status and Disease Control of Inflammatory Airway Diseases Airway Inflammation, Chronic Obstructive Pulmonary Disease (COPD) | Recruiting | First Affiliated Hospital of Ningbo University | 200 | 2025-08-01 | 2026-03-25 | |
| Fungal Status and Prognosis in ABPA ABPA, Allergic Bronchopulmonary Aspergillosis | Recruiting | Qianfoshan Hospital | 114 | 2025-07-01 | 2026-07-08 | |
| Pathogenesis and Inflammatory Phenotype of Allergic Bronchopulmonary Aspergillosis Allergic Bronchopulmonary Aspergillosis (ABPA) | Recruiting | Qianfoshan Hospital | 140 | 2025-05-10 | 2025-07-04 | |
| iMagIng pulmonaRy Aspergillosis Using Gallium-68-dEferoxamine Radiopharmaceutical: gallium-68-deferoxamine ([68Ga]Ga-DFO-B) - Pulmonary Aspergillosis, Chronic Pulmonary Aspergillosis | Phase 2 | Completed | Radboud University Medical Center | 10 | 2025-05-01 | 2026-08-18 |
| A Cohort Study of the Efficacy and Safety of Biologics in Patients With ABPA Biologic Agent - ABPA, Biologics | Recruiting | Qianfoshan Hospital | 50 | 2025-01-31 | 2026-04-17 | |
| Multicenter Registration Study on Allergic Bronchopulmonary Aspergillosis Allergic Bronchopulmonary Aspergillosis | Not yet recruiting | Peking University Third Hospital | 300 | 2024-10-15 | 2024-10-16 | |
| Allergic Bronchopulmonary Aspergillosis Prescreening Study Allergic Bronchopulmonary Aspergillosis, Asthma | Withdrawn | Community Pharmacology Services Ltd | 2024-01-10 | 2024-01-16 | ||
| A Randomized Trial of Prednisolone, Itraconazole, or Their Combination in Allergic Bronchopulmonary Aspergillosis Prednisolone, Itraconazole - Allergic Bronchopulmonary Aspergillosis | Phase 3 | Recruiting | Post Graduate Institute of Medical Education and Research, Chandigarh | 300 | 2023-12-01 | 2025-02-28 |
| Study to Evaluate Itraconazole Administered as Inhaled Dry Powder in Adults With Asthma and ABPA Itraconazole Powder, Placebo - ABPA | Phase 2 | Terminated | Pulmatrix Inc. | 8 | 2023-02-01 | 2024-04-02 |
| Modeling Bronchial Epithelium in Severe Asthma With Human Induced Pluripotent Stem Cells (iPSC) Blood sample - Severe Asthma, Allergic Bronchopulmonary Aspergillosis (ABPA) | Not applicable | Completed | University Hospital, Montpellier | 4 | 2022-11-29 | 2026-10-01 |
| Oral Itraconazole Versus Combination of Systemic Glucorticoids and Oral Itraconazole in CPA-ABPA Overlap Syndrome Prednisone tablet and Itraconazole, Oral itraconazole - Chronic Pulmonary Aspergillosis, Allergic Bronchopulmonary Aspergillosis | Not applicable | Recruiting | Post Graduate Institute of Medical Education and Research, Chandigarh | 104 | 2022-06-15 | 2026-04-07 |
| Interest of IgE Directed Against Recombinant Antigens of Aspergillus Fumigatus in the Diagnosis of Allergic Bronchopulmonary Aspergillosis (ABPA) Allergic Bronchopulmonary Aspergillosis (ABPA) | Completed | University Hospital, Rouen | 67 | 2022-01-08 | 2025-07-08 | |
| A Prospective Study on Optimizing Treatment for ABPA Prednisone tablet, itraconazole, Omalizumab - Allergic Bronchopulmonary Aspergillosis | Not applicable | Unknown | Shanghai Zhongshan Hospital | 100 | 2021-11-15 | 2021-11-22 |
| Immune Profiles in CF Fungal Infection Cystic Fibrosis, Fungal Infection | Completed | University of Alabama at Birmingham | 24 | 2021-02-10 | 2024-07-18 | |
| ML-Based ABPA Recurrence Prediction and Clinical Utility ABPA, Allergic Bronchopulmonary Aspergillosis | Recruiting | Qianfoshan Hospital | 200 | 2021-01-01 | 2026-07-20 | |
| Multi-Omics Inflammatory Phenotype for ABPA Recurrence Risk Prediction Allergic Bronchopulmonary Aspergillosis (ABPA), Machine Learning | Recruiting | Qianfoshan Hospital | 300 | 2021-01-01 | 2026-06-01 |
Showing 20 of 42. Sign in to see all of them.
Asthma (10) · Cystic Fibrosis (6) · Invasive Pulmonary Aspergillosis (4) · Bronchiectasis (2) · Pulmonary Aspergillosis (2) · Pulmonary Disease, Chronic Obstructive (2) · Anemia (1) · Aspergillosis (1) · Blastomycosis (1) · Candidiasis, Chronic Mucocutaneous (1) · Candidiasis, Invasive (1) · Candidiasis, Vulvovaginal (1) · Coccidioidomycosis (1) · Diphtheria (1)
Bacterial Infections and Mycoses (42) · Hypersensitivity (42) · Hypersensitivity, Immediate (42) · Immune System Diseases (42) · Infections (42) · Lung Diseases (42) · Respiratory Hypersensitivity (42) · Respiratory Tract Diseases (42) · Respiratory Tract Infections (42) · Aspergillosis (41) · Lung Diseases, Fungal (41) · Mycoses (41) · Pulmonary Aspergillosis (40) · Bronchial Diseases (11) · Lung Diseases, Obstructive (11)
Itraconazole (6) · Glucocorticoids (4) · Prednisolone (4) · Azoles (2) · Omalizumab (2) · Prednisone (2) · Voriconazole (2) · benralizumab (2) · Biological Factors (1) · Blood Specimen Collection (1) · Cholecalciferol (1) · GSK1278863 (1) · Reference Standards (1) · Steroids (1) · Tomography, X-Ray Computed (1)
Post Graduate Institute of Medical Education and Research, Chandigarh (9) · Qianfoshan Hospital (9) · GlaxoSmithKline (2) · Novartis Pharmaceuticals (2) · Pulmatrix Inc. (2) · University of Pittsburgh (2) · Baylor Research Institute (1) · Community Pharmacology Services Ltd (1) · First Affiliated Hospital of Ningbo University (1) · Peking University Third Hospital (1) · Poitiers University Hospital (1) · Radboud University Medical Center (1) · Rambam Health Care Campus (1) · Regeneron Pharmaceuticals (1) · Scynexis, Inc. (1)
China (11) · India (11) · United States (10) · United Kingdom (9) · France (8) · Germany (5) · Netherlands (5) · Australia (3) · Belgium (3) · Poland (3) · Romania (3) · Austria (2) · Bulgaria (2) · Hungary (2) · Italy (2)
Jay K Kolls, MD (2) · Qian Qi (2) · Ritesh Agarwal, MD, DM (2) · Chris Cabell, MD (1) · David Denning, FRCP, FRC Path, FIDSA, FMedSci (1) · Joseph M Pilewski, MD (1) · Lea Bentur, Prof. (1) · Margaret Wasilewski, MD (1) · Meiling Jin, MD (1)
PMID 33027187, PMID 23359515, PMID 26302738, PMID 26585431, PMID 27011794, PMID 28530849, PMID 29331473, PMID 30049743, PMID 30561849, PMID 33293212, PMID 33744933, PMID 34739194, PMID 34764182, PMID 36005278, PMID 36565721, PMID 36739866, PMID 38383961, PMID 38387646, PMID 38461089, PMID 39918069, PMID 42845221
2019 (2), P50HL084932 (2), 2016 (1), 2017 (1), 2023 (1)